Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
PaperCitations, authors & open-access status
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 373 citations, 2019 year and green oa status.
373
Citations
2019
Year
green
OA Status